MabVax Therapeutics Enters Into Exchange Agreements To Issue Common … – MarketWatch

MabVax Therapeutics Enters Into Exchange Agreements To Issue Common
MarketWatch
… MabVax Therapeutics Holdings, Inc. (otcqb:MBVX), acancer diagnostic and immunotherapy company, today announced that it had successfully restructured approximately $5.2 Million of outstanding Series A-1and B convertible preferred stock and warrants

and more

…read more

Scroll to Top